SCHEMBL48930

SCHEMBL48930

CCCNC(C)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11332518 0.97
SCHEMBL11344167 0.97
Calcium SCHEMBL30175380 0.97
Hydrochloric Acid SCHEMBL4188400 0.97
SCHEMBL11348342 0.97
Dimethylamine SCHEMBL11340752 0.94 PAOX (0.60)
Methylamine SCHEMBL27406333 0.94
SCHEMBL19881250 0.89 EPHX1 (0.58)
SCHEMBL9921401 0.84 PAOX (0.75)
SCHEMBL12217837 0.84 PAOX (0.75)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2538 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120020119-A Process for preparing N- (2-substituted ethyl) amides and N-vinyl amides 中国石油化工股份有限公司 2025-05-20 CN claimed
US-20240239759-A1 ISOXAZOLINE COMPOSITIONS AND THEIR USE AS ANTIPARASITICS INTERVET INC. (US) 2024-07-18 US claimed
CN-111295376-B Injectable isoxazoline pharmaceutical composition and use thereof against parasite infestations 英特维特国际股份有限公司 2024-05-24 CN claimed
EP-4358941-A1 PALATABLE VETERINARY COMPOSITIONS Intervet International B.V. (NL) 2024-05-01 EP claimed
US-20240122849-A1 ISOXAZOLINE COMPOSITIONS AND USE THEREOF IN THE PREVENTION OR TREATMENT OF PARASITE INFESTATIONS IN ANIMALS INTERVET INC. (US) 2024-04-18 US claimed
EP-4351341-A1 TICK CONTROL METHODS Intervet International B.V. (NL) 2024-04-17 EP claimed
CN-117545473-A Palatable veterinary compositions 英特维特国际股份有限公司 2024-02-09 CN claimed
EP-4316522-A2 INJECTABLE ISOXAZOLINE PHARMACEUTICAL COMPOSITIONS AND THEIR USE AGAINST PARASITE INFESTATION Intervet International B.V. (NL) 2024-02-07 EP claimed
US-11890275-B2 Therapeutic compounds CELGENE QUANTICEL RESEARCH, INC. 2024-02-06 US claimed
EP-3082867-B1 ISOXAZOLINE COMPOSITIONS AND USE THEREOF IN THE PREVENTION OR TREATMENT OF PARASITE INFESTATIONS IN ANIMALS INTERVET INT BV (NL) 2024-01-17 EP claimed
US-5166039-A Solution of hydrogen peroxide and amide for applying to resin coated surfaces HOYA CORPORATION (JP) 1992-11-24 US claimed
EP-0459702-A1 Azole Derivatives ZENECA LIMITED (GB) 1991-12-04 EP claimed
US-5037724-A Solution of hyrogen peroxide and formamide, acetamide or propionamide HOYA CORPORATION (JP) 1991-08-06 US claimed
EP-0238357-B1 1,2,4-TRIAZINONE DERIVATIVES, THEIR PREPARATION AND USE Sankyo Company Limited (JP) 1991-05-29 EP claimed
EP-0007470-B1 CEPHEM COMPOUNDS, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1983-10-12 EP claimed
EP-0028940-B1 ANTIARRHYTHMIC TETRAHYDRONAPHTHALENE DERIVATIVES E.R. Squibb &amp; Sons, Inc. (US) 1983-09-07 EP claimed
US-4268510-A DEMETHANIZATION, METABOLISM, RUMEN IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) 1981-05-19 US claimed
US-4268509-A BACTERICIDES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1981-05-19 US claimed
EP-0010348-A1 Heterocyclic trichloromethyl derivatives, process for their preparation and their use IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1980-04-30 EP claimed
EP-0007470-A2 Cephem compounds, processes for their preparation and pharmaceutical compositions containing them FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1980-02-06 EP claimed